Cubist Systematic Strategies’s Rigel Pharmaceuticals RIGL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,264
Closed -$393K 2170
2024
Q3
$393K Buy
24,264
+11,064
+84% +$179K ﹤0.01% 1038
2024
Q2
$109K Buy
13,200
+6,886
+109% +$56.6K ﹤0.01% 1164
2024
Q1
$93.4K Buy
+6,314
New +$93.4K ﹤0.01% 1827
2023
Q3
Sell
-10,124
Closed -$131K 2481
2023
Q2
$131K Sell
10,124
-4,676
-32% -$60.3K ﹤0.01% 1765
2023
Q1
$195K Sell
14,800
-12,447
-46% -$164K ﹤0.01% 2225
2022
Q4
$409K Buy
27,247
+10,277
+61% +$154K ﹤0.01% 2291
2022
Q3
$200K Buy
16,970
+9,502
+127% +$112K ﹤0.01% 2984
2022
Q2
$84K Buy
7,468
+5,638
+308% +$63.4K ﹤0.01% 3472
2022
Q1
$55K Sell
1,830
-270
-13% -$8.12K ﹤0.01% 3335
2021
Q4
$56K Buy
2,100
+1,439
+218% +$38.4K ﹤0.01% 3297
2021
Q3
$24K Buy
+661
New +$24K ﹤0.01% 2879
2021
Q2
Sell
-3,615
Closed -$124K 3067
2021
Q1
$124K Buy
3,615
+968
+37% +$33.2K ﹤0.01% 2602
2020
Q4
$93K Sell
2,647
-2,982
-53% -$105K ﹤0.01% 2416
2020
Q3
$135K Buy
+5,629
New +$135K ﹤0.01% 2234
2019
Q4
Sell
-3,719
Closed -$70K 2525
2019
Q3
$70K Buy
3,719
+2,507
+207% +$47.2K ﹤0.01% 1989
2019
Q2
$32K Sell
1,212
-6,187
-84% -$163K ﹤0.01% 2363
2019
Q1
$190K Sell
7,399
-1,053
-12% -$27K 0.01% 1809
2018
Q4
$194K Buy
8,452
+6,336
+299% +$145K 0.01% 1555
2018
Q3
$68K Sell
2,116
-3,940
-65% -$127K ﹤0.01% 1646
2018
Q2
$171K Buy
6,056
+4,037
+200% +$114K 0.01% 1406
2018
Q1
$71K Buy
+2,019
New +$71K ﹤0.01% 1647
2017
Q4
Sell
-3,699
Closed -$94K 2064
2017
Q3
$94K Buy
+3,699
New +$94K 0.01% 1642
2017
Q1
Sell
-2,057
Closed -$49K 1816
2016
Q4
$49K Sell
2,057
-1,144
-36% -$27.3K ﹤0.01% 1583
2016
Q3
$117K Buy
+3,201
New +$117K 0.01% 1431
2016
Q2
Sell
-1,350
Closed -$28K 1851
2016
Q1
$28K Buy
+1,350
New +$28K ﹤0.01% 1517
2015
Q4
Sell
-1,801
Closed -$44K 1909
2015
Q3
$44K Buy
+1,801
New +$44K ﹤0.01% 1730
2015
Q2
Sell
-2,216
Closed -$79K 2011
2015
Q1
$79K Buy
+2,216
New +$79K ﹤0.01% 1705